1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking
- PMID: 17600374
- DOI: 10.1002/jnr.21382
1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking
Abstract
Multiple sclerosis (MS) is a complex neurodegenerative disease whose pathogenesis involves genetic and environmental risk factors leading to an aberrant, neuroantigen-specific, CD4+ T cell-mediated autoimmune response. In support of the hypothesis that vitamin D3 may reduce MS risk and severity, we found that vitamin D3 and 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) inhibited induction of experimental autoimmune encephalomyelitis (EAE), an MS model. To investigate how 1,25-(OH)2D3 could carry out anti-inflammatory functions, we administered 1,25-(OH)2D3 or a placebo to mice with EAE, and subsequently analyzed clinical disease, chemokines, inducible nitric oxide synthase (iNOS), and recruitment of dye-labeled monocytes. The 1,25-(OH)2D3 treatment significantly reduced clinical EAE severity within 3 days. Sharp declines in chemokines, inducible iNOS, and CD11b+ monocyte recruitment into the central nervous system (CNS) preceded this clinical disease abatement in the 1,25-(OH)2D3-treated animals. The 1,25-(OH)2D3 did not directly and rapidly inhibit chemokine synthesis in vivo or in vitro. Rather, the 1,25-(OH)2D3 rapidly stimulated activated CD4+ T cell apoptosis in the CNS and spleen. Collectively, these results support a model wherein inflammation stimulates a natural anti-inflammatory feedback loop. The activated inflammatory cells produce 1,25-(OH)2D3, and this hormone subsequently enhances the apoptotic death of inflammatory CD4+ T cells, removing the driving force for continued inflammation. In this way, the sunlight-derived hormone could reduce the risk of chronic CNS inflammation and autoimmune-mediated neurodegenerative disease.
Copyright 2007 Wiley-Liss, Inc.
Similar articles
-
Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis.Physiol Genomics. 2004 Jul 8;18(2):141-51. doi: 10.1152/physiolgenomics.00003.2004. Physiol Genomics. 2004. PMID: 15138306
-
The Ifng gene is essential for Vdr gene expression and vitamin D₃-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model.J Immunol. 2012 Sep 15;189(6):3188-97. doi: 10.4049/jimmunol.1102925. Epub 2012 Aug 15. J Immunol. 2012. PMID: 22896638
-
Augmentation of monocyte chemotaxis by 1 alpha,25-dihydroxyvitamin D3. Stimulation of defective migration of AIDS patients.J Immunol. 1990 Oct 15;145(8):2459-64. J Immunol. 1990. PMID: 2212648
-
Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis.J Immunol. 1998 Sep 15;161(6):2667-71. J Immunol. 1998. PMID: 9743321 Review.
-
Multiple sclerosis and vitamin D: an update.Eur J Clin Nutr. 2004 Aug;58(8):1095-109. doi: 10.1038/sj.ejcn.1601952. Eur J Clin Nutr. 2004. PMID: 15054436 Review.
Cited by
-
In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling.Cells. 2023 Sep 15;12(18):2291. doi: 10.3390/cells12182291. Cells. 2023. PMID: 37759513 Free PMC article.
-
Radiological Benefits of Vitamin D Status and Supplementation in Patients with MS-A Two-Year Prospective Observational Cohort Study.Nutrients. 2023 Mar 17;15(6):1465. doi: 10.3390/nu15061465. Nutrients. 2023. PMID: 36986195 Free PMC article.
-
How Does Vitamin D Affect Immune Cells Crosstalk in Autoimmune Diseases?Int J Mol Sci. 2023 Feb 28;24(5):4689. doi: 10.3390/ijms24054689. Int J Mol Sci. 2023. PMID: 36902117 Free PMC article. Review.
-
Vitamin D Supplementation Practices among Multiple Sclerosis Patients and Professionals.J Clin Med. 2022 Dec 8;11(24):7278. doi: 10.3390/jcm11247278. J Clin Med. 2022. PMID: 36555896 Free PMC article.
-
Seasonal and monthly variation in multiple sclerosis relapses: a systematic review and meta-analysis.Acta Neurol Belg. 2022 Dec;122(6):1447-1456. doi: 10.1007/s13760-022-02103-y. Epub 2022 Sep 28. Acta Neurol Belg. 2022. PMID: 36171477 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials